0000899243-22-019969.txt : 20220527 0000899243-22-019969.hdr.sgml : 20220527 20220527174956 ACCESSION NUMBER: 0000899243-22-019969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220525 FILED AS OF DATE: 20220527 DATE AS OF CHANGE: 20220527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Auerbach Michael CENTRAL INDEX KEY: 0001746080 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40493 FILM NUMBER: 22979421 MAIL ADDRESS: STREET 1: 158 HESTER STREET STREET 2: APT 7F CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATAI Life Sciences N.V. CENTRAL INDEX KEY: 0001840904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (617) 699-5876 MAIL ADDRESS: STREET 1: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: ATAI Life Sciences B.V. DATE OF NAME CHANGE: 20210115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-25 0 0001840904 ATAI Life Sciences N.V. ATAI 0001746080 Auerbach Michael C/O SUBVERSIVE ATAI, LLC, 217 CENTRE STREET, SUITE 122 NEW YORK NY 10013 1 0 0 0 Stock Option 3.84 2022-05-25 4 A 0 64000 0.00 A 2032-05-25 Common Shares 64000 64000 D The stock option shall vest on the earlier of the day before ATAI Life Sciences N.V.'s next annual meeting or May 25, 2023. /s/ Ryan Barrett, Attorney-in-fact 2022-05-27